G Janka

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. ncbi Modern management of children with haemophagocytic lymphohistiocytosis
    Gritta E Janka
    Department of Haematology and Oncology, Children's Hospital, University of Hamburg, Hamburg, Germany
    Br J Haematol 124:4-14. 2004
  2. ncbi [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-0
    G E Janka-Schaub
    Abt für Pädiatrische Hämatologie und Onkologie, Universitätskinderklinik Hamburg
    Klin Padiatr 211:233-8. 1999
  3. ncbi Hemophagocytic lymphohistiocytosis: when the immune system runs amok
    G Janka
    Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Klin Padiatr 221:278-85. 2009
  4. ncbi Familial and acquired hemophagocytic lymphohistiocytosis
    G E Janka
    Department of Hematology and Oncology, Children s University Hospital, Hamburg, Germany
    Annu Rev Med 63:233-46. 2012
  5. ncbi Hemophagocytic syndromes
    Gritta E Janka
    Department of Hematology and Oncology, Children s Hospital, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
    Blood Rev 21:245-53. 2007
  6. ncbi Familial and acquired hemophagocytic lymphohistiocytosis
    Gritta E Janka
    Department of Hematology and Oncology, Children s Hospital, University of Hamburg, Hamburg, Germany
    Eur J Pediatr 166:95-109. 2007
  7. ncbi [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]
    U zur Stadt
    Abt für Pädiatrische Hämatologie und Onkologie, Universitätskinderklinik Eppendorf, Hamburg
    Klin Padiatr 212:169-73. 2000
  8. ncbi From neonates to adolescents--the diagnostic significance of pitted erythrocytes in hyposplenic and asplenic children
    K Lehmberg
    Department of Paediatric Haematology and Oncology, Children s Hospital, University of Hamburg, Hamburg
    Klin Padiatr 219:339-42. 2007
  9. ncbi Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R*2
    Jin Yamamura
    University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Magn Reson Imaging 32:1104-9. 2010
  10. ncbi Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia
    Ulrike B Graubner
    University Children s Hospital, Department of Hematology and Oncology, Munich, Germany
    Pediatr Blood Cancer 50:259-63. 2008

Collaborators

  • R Pieters
  • K Lehmberg
  • Jin Yamamura
  • Ulrike B Graubner
  • Joachim Graessner
  • Regine Grosse
  • Roland Fischer
  • Gerhard Adam
  • U zur Stadt
  • D O Harms
  • Gabriele Escherich
  • G E Janka-Schaub
  • Simone Porzig
  • Norbert Jorch
  • Rüdiger Wessalowski
  • Reinhard Kolb
  • S Völpel
  • M Schrappe
  • W Nurnberger
  • H Kabisch
  • S Schluter
  • P Gutjahr
  • N Jorch
  • H J Spaar
  • A J Veerman
  • M L den Boer

Detail Information

Publications10

  1. ncbi Modern management of children with haemophagocytic lymphohistiocytosis
    Gritta E Janka
    Department of Haematology and Oncology, Children's Hospital, University of Hamburg, Hamburg, Germany
    Br J Haematol 124:4-14. 2004
  2. ncbi [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-0
    G E Janka-Schaub
    Abt für Pädiatrische Hämatologie und Onkologie, Universitätskinderklinik Hamburg
    Klin Padiatr 211:233-8. 1999
    ..Additional prognostic criteria are therefore urgently needed. In a retrospective Dutch study in childhood ALL drug sensitivity testing with the MTT assay was identified as a new highly significant prognostic factor...
  3. ncbi Hemophagocytic lymphohistiocytosis: when the immune system runs amok
    G Janka
    Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Klin Padiatr 221:278-85. 2009
    ..Suppression of the severe hyperinflammation can be achieved with immunosuppressive and immunomodulatory agents and cytostatic drugs. Patients with genetic HLH have to undergo stem cell transplantation for cure...
  4. ncbi Familial and acquired hemophagocytic lymphohistiocytosis
    G E Janka
    Department of Hematology and Oncology, Children s University Hospital, Hamburg, Germany
    Annu Rev Med 63:233-46. 2012
    ..Treatment of HLH includes immune-suppressive and immune-modulatory agents, cytostatic drugs, and biological response modifiers. For patients with FHL, stem cell transplantation is indicated and can be curative...
  5. ncbi Hemophagocytic syndromes
    Gritta E Janka
    Department of Hematology and Oncology, Children s Hospital, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
    Blood Rev 21:245-53. 2007
    ..Awareness of the clinical symptoms and of the diagnostic criteria of HLH is important to start life-saving therapy with immunosuppressive/immunomodulatory agents in time...
  6. ncbi Familial and acquired hemophagocytic lymphohistiocytosis
    Gritta E Janka
    Department of Hematology and Oncology, Children s Hospital, University of Hamburg, Hamburg, Germany
    Eur J Pediatr 166:95-109. 2007
    ..In conclusion, awareness of the clinical symptoms and of the diagnostic criteria of HLH is crucial in order not to overlook HLH and to start life-saving therapy in time...
  7. ncbi [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]
    U zur Stadt
    Abt für Pädiatrische Hämatologie und Onkologie, Universitätskinderklinik Eppendorf, Hamburg
    Klin Padiatr 212:169-73. 2000
    ..At the end of induction therapy, bone marrow was obtained for cytomorphologic and molecular analysis...
  8. ncbi From neonates to adolescents--the diagnostic significance of pitted erythrocytes in hyposplenic and asplenic children
    K Lehmberg
    Department of Paediatric Haematology and Oncology, Children s Hospital, University of Hamburg, Hamburg
    Klin Padiatr 219:339-42. 2007
    ..A simple method with reliable reference values is required to determine a patient's splenic function and thereby assess the risk of systemic infection...
  9. ncbi Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R*2
    Jin Yamamura
    University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Magn Reson Imaging 32:1104-9. 2010
    ..To assess regional iron distribution by magnetic resonance imaging (MRI)-R(2)* within the heart of patients with β-thalassemia major (TM) and other iron overload diseases...
  10. ncbi Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia
    Ulrike B Graubner
    University Children s Hospital, Department of Hematology and Oncology, Munich, Germany
    Pediatr Blood Cancer 50:259-63. 2008
    ..Infections are a major cause of morbidity and mortality in childhood acute lymphoblastic leukemia (ALL) and only limited information is available on infectious complications...